DS-006

N/A

Report date: 2025/01/26 17:59:38

Base Information

Drug NameDS-006
Drug Alias NamePD-L1 checkpoint inhibitor/anti-HER2 antibody (Dartsbio Pharmaceuticals)anti-PD-L1/anti-HER-2 bispecific monoclonal antibody (Dartsbio Pharmaceuticals)DS-006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1Receptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDartsbio Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDartsbio Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A